CAITLYN STOWE: Open Payments
NPI 1730317645 · WEXFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,542 in 283 payments from 21 companies in 2025. Trend: 2023 $3,869 · 2024 $5,712 · 2025 $4,542
Food & beverage: $4,473Education: $69
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 50 | $876 |
| Janssen Biotech, Inc. | 57 | $780 |
| Galderma Laboratories, L.P. | 27 | $366 |
| GENZYME CORPORATION | 11 | $325 |
| UCB, Inc. | 21 | $271 |
| LEO Pharma Inc. | 13 | $266 |
| Incyte Corporation | 13 | $226 |
| Lilly USA, LLC | 15 | $225 |
| Arcutis Biotherapeutics, Inc. | 10 | $216 |
| Novartis Pharmaceuticals Corporation | 13 | $200 |
Products named: RINVOQ, TREMFYA, DUPIXENT, NEMLUVIO, Bimzelx, OPZELURA, Zoryve, ADBRY.
Industry payments across PA — which companies pay providers there.
